Screener
Nurix Therapeutics, Inc. NRIX Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
| Line item | May 31,2026 | November 30,2025 |
|---|---|---|
| Operating lease liabilities, current | 3,221 | 2,824 |
| Deferred revenue, current | 13,324 | 17,580 |
| Total current liabilities | 72,020 | 86,471 |
| Operating lease liabilities, net of current portion | 54,922 | 52,906 |
| Deferred revenue, net of current portion | 5,971 | 10,011 |
| Total liabilities | 132,913 | 149,388 |
| Commitments and contingencies (Note 6) | ||
| Stockholdersʼ equity: |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Nurix Therapeutics, Inc.'s operating lease liabilities?
- Nurix Therapeutics, Inc. (NRIX) reported operating lease liabilities of $54.92M in Q1 2026.
- How has Nurix Therapeutics, Inc.'s operating lease liabilities changed year-over-year?
- Nurix Therapeutics, Inc.'s operating lease liabilities increased by 17.6% year-over-year, from $46.7M to $54.92M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s operating lease liabilities has grown at a 37.1% compound annual growth rate (CAGR), from $10.9M to $52.91M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Nurix Therapeutics, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude